Logo image of XEC

Cimarex Energy Company (XEC) Stock Fundamental Analysis

NYSE:XEC - New York Stock Exchange, Inc. -

87.2  -2.8 (-3.11%)

After market: 87.26 +0.06 (+0.07%)

Fundamental Rating

3

Taking everything into account, XEC scores 3 out of 10 in our fundamental rating. XEC was compared to 208 industry peers in the Oil, Gas & Consumable Fuels industry. XEC may be in some trouble as it scores bad on both profitability and health. XEC is not priced too expensively while it is growing strongly. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year XEC was profitable.

1.2 Ratios

Industry RankSector Rank
ROA -0.51%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 0.91%
PM (TTM) -1.19%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

There is no outstanding debt for XEC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

Based on the Altman-Z score of 1.62, we must say that XEC is in the distress zone and has some risk of bankruptcy.
XEC has a Debt/Equity ratio of 1.13. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 1.13
Debt/FCF N/A
Altman-Z 1.62
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 1.23 indicates that XEC should not have too much problems paying its short term obligations.
A Quick Ratio of 1.20 indicates that XEC should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 1.2

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 153.24% over the past year.
The Earnings Per Share has been growing by 21.26% on average over the past years. This is a very strong growth
The Revenue has grown by 13.58% in the past year. This is quite good.
Measured over the past years, XEC shows a small growth in Revenue. The Revenue has been growing by 1.42% on average per year.
EPS 1Y (TTM)153.24%
EPS 3Y-31.98%
EPS 5Y21.26%
EPS Q2Q%509.8%
Revenue 1Y (TTM)13.58%
Revenue growth 3Y-6.69%
Revenue growth 5Y1.42%
Sales Q2Q%185.66%

3.2 Future

XEC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 50.07% yearly.
The Revenue is expected to grow by 12.48% on average over the next years. This is quite good.
EPS Next Y570.49%
EPS Next 2Y183.31%
EPS Next 3Y92.18%
EPS Next 5Y50.07%
Revenue Next Year74.51%
Revenue Next 2Y38.21%
Revenue Next 3Y21.09%
Revenue Next 5Y12.48%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
XEC Yearly Revenue VS EstimatesXEC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B
XEC Yearly EPS VS EstimatesXEC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 4 6 8 10

4

4. Valuation

4.1 Price/Earnings Ratio

XEC is valuated correctly with a Price/Earnings ratio of 15.94.
XEC's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.03.
Based on the Price/Forward Earnings ratio of 7.39, the valuation of XEC can be described as very cheap.
XEC's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.28.
Industry RankSector Rank
PE 15.94
Fwd PE 7.39
XEC Price Earnings VS Forward Price EarningsXEC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 19.16
XEC Per share dataXEC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as XEC's earnings are expected to grow with 92.18% in the coming years.
PEG (NY)0.03
PEG (5Y)0.75
EPS Next 2Y183.31%
EPS Next 3Y92.18%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.24%, XEC has a reasonable but not impressive dividend return.
Compared to an average S&P500 Dividend Yield of 2.40, XEC's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.24%

5.2 History

The dividend of XEC is nicely growing with an annual growth rate of 9.11%!
XEC has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)9.11%
Div Incr YearsN/A
Div Non Decr YearsN/A
XEC Yearly Dividends per shareXEC Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 0.2 0.4 0.6 0.8

5.3 Sustainability

The earnings of XEC are negative and hence is the payout ratio. XEC will probably not be able to sustain this dividend level.
The dividend of XEC is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-372.67%
EPS Next 2Y183.31%
EPS Next 3Y92.18%

Cimarex Energy Company

NYSE:XEC (9/30/2021, 8:09:16 PM)

After market: 87.26 +0.06 (+0.07%)

87.2

-2.8 (-3.11%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.06%
Inst Owner Change0%
Ins Owners0.18%
Ins Owner Change0%
Market Cap8.97B
Analysts82.2
Price Target88.34 (1.31%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.24%
Yearly Dividend1.08
Dividend Growth(5Y)9.11%
DP-372.67%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 15.94
Fwd PE 7.39
P/S 4.02
P/FCF N/A
P/OCF N/A
P/B 5.11
P/tB N/A
EV/EBITDA 19.16
EPS(TTM)5.47
EY6.27%
EPS(NY)11.8
Fwd EY13.53%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS21.67
BVpS17.08
TBVpSN/A
PEG (NY)0.03
PEG (5Y)0.75
Profitability
Industry RankSector Rank
ROA -0.51%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 0.91%
PM (TTM) -1.19%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 1.13
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 1.2
Altman-Z 1.62
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)153.24%
EPS 3Y-31.98%
EPS 5Y21.26%
EPS Q2Q%509.8%
EPS Next Y570.49%
EPS Next 2Y183.31%
EPS Next 3Y92.18%
EPS Next 5Y50.07%
Revenue 1Y (TTM)13.58%
Revenue growth 3Y-6.69%
Revenue growth 5Y1.42%
Sales Q2Q%185.66%
Revenue Next Year74.51%
Revenue Next 2Y38.21%
Revenue Next 3Y21.09%
Revenue Next 5Y12.48%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A